GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » Price-to-Owner-Earnings

Huadong Medicine Co (SZSE:000963) Price-to-Owner-Earnings : 32.61 (As of May. 05, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co Price-to-Owner-Earnings?

As of today (2024-05-05), Huadong Medicine Co's share price is ¥32.94. Huadong Medicine Co's Owner Earnings per Share (TTM) ended in Mar. 2024 was ¥1.01. It's Price-to-Owner-Earnings for today is 32.61.


The historical rank and industry rank for Huadong Medicine Co's Price-to-Owner-Earnings or its related term are showing as below:

SZSE:000963' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.83   Med: 38.34   Max: 62.1
Current: 32.65

During the past 13 years, the highest Price-to-Owner-Earnings of Huadong Medicine Co was 62.10. The lowest was 12.83. And the median was 38.34.


SZSE:000963's Price-to-Owner-Earnings is ranked worse than
59.43% of 419 companies
in the Drug Manufacturers industry
Industry Median: 28.05 vs SZSE:000963: 32.65

As of today (2024-05-05), Huadong Medicine Co's share price is ¥32.94. Huadong Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.68. Therefore, Huadong Medicine Co's PE Ratio for today is 19.58.

As of today (2024-05-05), Huadong Medicine Co's share price is ¥32.94. Huadong Medicine Co's EPS without NRI for the trailing twelve months (TTM) ended in was ¥1.70. Therefore, Huadong Medicine Co's PE Ratio without NRI for today is 19.38.

During the past 13 years, Huadong Medicine Co's highest PE Ratio without NRI was 40.62. The lowest was 10.63. And the median was 27.33.


Huadong Medicine Co Price-to-Owner-Earnings Historical Data

The historical data trend for Huadong Medicine Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co Price-to-Owner-Earnings Chart

Huadong Medicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.18 22.72 47.80 53.06 42.18

Huadong Medicine Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.36 47.66 44.00 42.18 30.72

Competitive Comparison of Huadong Medicine Co's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Huadong Medicine Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huadong Medicine Co's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huadong Medicine Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Huadong Medicine Co's Price-to-Owner-Earnings falls into.



Huadong Medicine Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Huadong Medicine Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=32.94/1.01
=32.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huadong Medicine Co  (SZSE:000963) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Huadong Medicine Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Huadong Medicine Co (SZSE:000963) Business Description

Traded in Other Exchanges
N/A
Address
468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006
Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines